Impact of magnetic nanoparticles in biomedical applications

Recent Patents on Drug Delivery and Formulation

Volumn 3, Issue 2, 2009, Pages 153-161

  Naqvi, Saba ^a   Samim, Mohammad ^a   Dinda, Amit K ^b   Iqbal, Zeenat ^b   Telagoanker, Sushma ^c   Ahmed, Farhan J ^c   Maitra, Amaranth ^c  

^a HAMDARD UNIVERSITY   (India)

^b ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^c HAMDARD UNIVERSITY   (India)

Author keywords

Biological separators; Diagnostic agents; Drug delivery; Hyperthermia; Imaging; Magnetic nanoparticles; Surface modifications

Indexed keywords

C REACTIVE PROTEIN; CONTRAST MEDIUM; DIAGNOSTIC AGENT; FERROMAGNETIC MATERIAL; MACROGOL; MAGNETITE; METAL OXIDE; NANOMATERIAL; NANOPARTICLE; SUPERPARAMAGNETIC IRON OXIDE NANOPARTICLE; VASCULOTROPIN; FERRIC ION;

ARTICLE; ATHEROSCLEROSIS; BIOCOMPATIBILITY; BIOSEPARATION; CANCER DIAGNOSIS; CANCER THERAPY; COMBINATORIAL CHEMISTRY; DIAGNOSTIC IMAGING; DRUG DELIVERY SYSTEM; HUMAN; HYPERTHERMIC THERAPY; INFLAMMATORY DISEASE; MAGNETIC FIELD; MATERIAL COATING; MICROPARTICLE ENZYME IMMUNOASSAY; NANOMEDICINE; NEOPLASM; NUCLEAR MAGNETIC RESONANCE IMAGING; PARTICLE SIZE; PATENT; PRIORITY JOURNAL; SEPARATION TECHNIQUE; SURFACE PROPERTY; TISSUE SPECIFICITY; ANIMAL; BIOMEDICAL ENGINEERING; CHEMISTRY; IMMUNOMAGNETIC SEPARATION; MAGNETISM; METHODOLOGY; NANOTECHNOLOGY;

ANIMALS; BIOMEDICAL ENGINEERING; DRUG DELIVERY SYSTEMS; FERRIC COMPOUNDS; HUMANS; HYPERTHERMIA, INDUCED; IMMUNOMAGNETIC SEPARATION; MAGNETICS; NANOPARTICLES; NANOTECHNOLOGY; NEOPLASMS; PATENTS AS TOPIC; SURFACE PROPERTIES;

EID: 68849127807     PISSN: 18722113     EISSN: None     Source Type: Journal    
DOI: 10.2174/187221109788452249     Document Type: Article

References (88)

1. Schwertmann U, Cornell RM. Iron oxides in the laboratory: Preparation and characterization. Weinheim, Cambridge: VCH 1991; 137.
2. Batlle X, Labarta A. Finite size effects in fine particles: Magnetic and transport properties. J Phys D: Apply Phys 2002; 35 (6): R15-R42 (1).
3. Portet D, Denizot B, Rump E, Le Jeune JJ, Jallet P. Nonpolymeric coatings of Iron oxide colloids for biological use as magnetic resonance imaging contrast agents. J Coll Interf Sci 2001; 238 (1): 37-42.
4. Philipse AP,Van Bruggen MPB, Pathmamanoharan C. Magnetic silica dispersions: Preparation and stability of surface-modified silica particles with a magnetic core. Langmuir1994; 10: 92.
5. Garcell L, Morales MP, Andres-Verges M, Tartaj P, Cerna CJ. interfacial and rheological characteristics of maghemite aqueous suspensions. J Coll Interf Sci 1998; 205 (2): 470-475.
6. Butter K, Bomans PHH, Frederik PM, Vroege GJ, Philipse A. Direct observation of dipolar chains in iron ferrofluids by cryogenic electron microscopy. Nature Mater. 2003; 2 (2): 88-91.
7. Gupta AK, Gupta M. Synthesis & surface engineering of super paramagnetic iron oxide nanoparticles for drug delivery & cellular targeting. Biomaterials 2005; 26 (18): 3995-4021.
8. Goya GF, Berquo TS, Fonseca FC. Static and dynamic magnetic properties of spherical magnetite nanoparticles. J Appl Phys 2003; 94 (5): 838-846.
9. Cheon, J.W., Seo. J.W., Lee, J.H.: US2008003159A1 (2008).
10. Sun, S.: US20070056401A1 (2007).
11. Jana NR, ChenY, Peng X. Size and shape controlled magnetic (Cr,Mn,Fe,Co,Ni,) oxide nanocrystals via a simple and general approach. Chem Mater. 2004; 16 (20): 3931-3935.
12. Cheon, J-W., Seo, J-W., Lee, J-H.: PCTKR003088 (2004).
13. Hu, R.-K., Chiu, H.-Y.: US20077175909 (2007)
14. Eyal, A., Vitner, A.: US20080067469A1 (2008).
15. Okinaka, K., Uegami, M.: US20026391450 (2002).
16. Matson, D.W., Fulton, J.L., Linehan, J.C., Bean, R.M., Brewer, T.D., Werpy, T.A., Darab, J.G.: US5652192 (1997).
17. Skold, C.N.: US20077169618B2 (2007).
18. Massart, R.: US4329241 (1982).
19. Khalafalla, S.E., Reimers, G.W., Rholl, S.A.: US4208294 (1980).
20. Ullman, E.F., Ghazarossian, V.E., Kurn, N., Weng, L.: US4935147 (1990).
21. Hasegawa, M., Hokkoku, S.: US4101435 (1978).
22. Palmacci, S., Josephson, L., US5262176 (1993).
23. Molday, R.S.: US4452773 (1984).
24. Miltenyi, S.: US5411863 (1995).
25. Mak S, Chen D. Binding and sulfonationation ofpoly (acrylic acid)on iron oxide nanoparticles: A novel magnetic strong acid cation nanoadsorbent. Macro Rapid Comm 2005; 26(19): 1567-1571.
26. Wu Y, Guo J, Yang W, Wang C, Fu S. Preparation and characterization of chitosan-(polyacrylic acid) polymer magnetic microspheres. Polymer 2006; 47: 5287-5294.
27. Chen, D.J., Chang, Y.H.: US20070116955A1 (2007).
28. Sun, X-D.: US20080057001A1 (2008).
29. Ritter, J.A., Ebner, A.D., Holland, C.E.: US20070231393 (2007).
30. Skalak S, Chien S (Eds). Network models of peripheral circulation. In: Handbook of Bioengineering, Mcgraw-HILL NY 1987; Ch 20.
31. Berger S.A, Goldsmith W, Lewis E.R(ed.),Physiological fluid mechanics. In: Introduction to Bioengineering. Oxford Uni Press 1996; 133-170.
32. Saltzman WM. Drug delivery-engineering principles for drug delivery. Oxford University press, New York 2001; 1(1): 137-144.
33. Ghassabian S, Ehtezazi T, Forutan SM, Mortazavi SA. Dexamethasone-loaded magnetic albumin microspheres: Preparation and in vitro release. Int J Pharm1996; 130(1): 49-55.
34. Goodwin S, Peterson C, Hoh C, Bitter C. Targeting and retention of magnetic targeted carriers (MTCs) enhancing intraarterial chemotherapy. J Magn Magn Mater.1999; 194: 132-139.
35. Song, S.-Y., Ham, S.-J., Park, S.-B. Gang, J.-G., Kim, H.-S., Shul, Y.-G.: WO2004096190 (2004).
36. Slade, R.A., Eaton, M.: US2007019753A1 (2007).
37. Penades, S., Lomas, M., Fuente, M.D.L., Rademacher, T.W.: US20060233712A1 (2006).
38. Perez, J., M., Josephson, L.,Weissleder, R.: WO098364 (2002).
39. Bahr, M.K., Berkov, D., Buske, N., Clement, J., Gornert, P., Hoffken, K., Kliche, K.O., Kober, T., Schnabelrauch, M., Vogt, S., Wagner, K., Gansav, C.: WO019405 (2001).
40. Reich, D.H., Chen, C.S., Chien, C.L., Meyer, G.J., Searson, P.C.: WO093140 (2002).
41. Pacey, A.: US20080019917A1 (2008).
42. Wachspress, H.: US4874346 (1989).
43. Li, H.C., Wang, W.: US20080053912 (2008).
44. Volkonsky, V.A., Dvukhshertnov, C.: US5549915 (1996).
45. Prasad, P.N., Bergey, E.J., Liebow, C., Levy, L.: US20036514481B1 (2003).
46. Jinbo,Y., Miyasaka, T., Ikeda, Y., Sekida, T., Naruse, K., Ando, M., Iwaki, S., Yoshino, K.: US5912247 (1999).
47. Whitehead, R.A., Chagnon, M.S., Groman, E.V., Josephson, L.: US4554088 (1985).
48. Josephson, L.: US4672040 (1987).
49. Chagnon, M.S.,Groman, E.V., Josephson, L., Whitehead, R.A.: US4628037 (1986).
50. Whitehead, R.A., Chagnon, M.S., Groman, E.V., Josephson, L.: US4554088 (1985).
51. Wang, C.-H.J., Shah, D.O.: US20006013531 (2000).
52. Lu, H., Yi, G., Chen, D., Guo, L., Cheng, J.: US20070059705A1 (2007).
53. Xu, B., Ho, P.L., Gu, H.: US20060292555A1 (2006).
54. Kausch, A.P., Narayanswami, S., Manning, J.E., Hamkalo, B.A.: US5508164 (1996).
55. O'Connor., Charles J., Sims, J.A.: US20020068187A1 (2002).
56. Ravel B, Carpenter EE, Harris VG. Oxidation of iron/gold core shell nanoparticles. JAppl Phys 2002; 91:10: 8195-8197.also published online in Virtual. J Nanoscale Sci Technol 2002; 5: 22.
57. Andres, R.P., Ng, A.T.: US20077186398 B2 (2007).
58. Ford, W., Wessels, J., Yasuda, A.: US20020072069A1 (2002).
59. Hyeon, T.H., Lee, I.S.: WO2008010687 (2008).
60. Wang, S.X., White, R.L., Webb, C.D., Li, G.: US20050100930A1 (2005).
61. Hong, C-Y.R.H., Herng-Er, H., Chau-Chung, W., Hong-Chang, Y., Shieh-Yueh, Y.: UA20070111331A1 (2007).
62. Jones SK, Winter JG, Winter GB. N. Treatment of experimental rabbit liver tumors by selectively targeted hyperthermia. Int J Hyperthermia 2002; 18(2): 117-128.
63. Jordan A, Scholz R. Presentation of a new magnetic field therapy system for the treatment of human solid tumors with magnetic field hyperthermia. J Magn Magn Mater. 2001; 225: 118-126.
64. Handy, E.S., Ivkov, R., Ellis-Busby, D., Foreman, A., Braunhut, S.J., Gwost, D.U., Ardman, B.: US20066997863 (2006).
65. Eaton M. Immuno-conjugates: Current status and future potential. J Drug Target 2002; 10 (7): 525-527.
66. Prasad, P.N., Bergey, E.J., Liebow, C., Levy, L.: US20036514481B1 (2003).
67. Halbreich A, Gorman EV, Raison D, Bouchaud C, Paturance S. Damage to the protein synthesizing apparatus in mouse liver in vivo by magnetocytolysis in the presence of hepatospecific magnetic nanoparticles. J Magn Magn Mater. 2002; 248(2): 276-285.
68. Wilk., P.J., Essig, M.N.: US20016231496 (2001).
69. Gudov, V.F., Vakhontov, N.E., Kharchenko, V.P., Dolotov, B.K., Belousov, E.L., Vinitsky., V.B., Kozlov, A.M., Pugachev, V.F.: US5067952 (1991).
70. Granov, A.M., Derkach, V.Y., Granov, D.A.: US5236410 (1993).
71. Leuschner, C., Kummar, C.S.S.R., Hansel, W., Hormes, J.: US2006030630 (2006) and WO2007021621 (2007).
72. Hyeon, T., Kim, J.Y., Cho, M.H., Kim, S.K., Lee, J. WO2008048074 (2008) and KR005154 (2007).
73. Chen, M.Y., Chau, C.M., Huang, H.Y., Chen, C.Y., Jiang, P.S., Lin, C.I.: US20070148095 (2007).
74. Akhtarri, M., Engel, J.: WO2006102377 (2006).
75. Hans ML, Lowman AM. Biodegradable nanoparticles for drug delivery and targeting. Curr Opin Solid State Mater.Sci 2002; 6: 319-327.
76. Pardoe H, Chua-Anusorn W, Pierre TG, Dobson J. Structural and magnetic properties of nanoscale iron oxide particles synthesized in the presence of dextran and polyvinyl alcohol. J Magn Magn Mat 2001; 225: 41-46.
77. Gruttner C, Teller J. New types of silica-fortified magnetic nanoparticles as tools for molecular biology applications. J Magn Magn Mater 1999; 194: 8-15.
78. Arias JL, Gallardo V, Gomez-Lopera SA, Plaza RC, Delgado AV. Synthesis and characterization of poly(ethyl-2-cyanoacrylate) nanoparticles with a magnetic core. J Control Release 2001; 77: 309-321.
79. Mornet S, Grasset F, Portier J. Maghemite/silica nanoparticles for biological applications. Eur Cells Mater. 2002; 3: 110-113.
80. Deng Y, Wang L, Yang W, Fu S, Elaissari A. Preparation of magnetic polymeric particles via inverse microemulsion polymerization process. J Magn Magn Mater. 2003; 257: 69-78.
81. Santra S, Tapec R, Theodoropoulou N, Dobson J, Hebard A, Tan W. Synthesis and characterization of silica-coated iron oxide nanorparticles in microemulsion: the effect of non-ionic surfactants. Langmuir 2001; 17: 2900-2906.
82. Carpenter EE. Iron nanoparticles as potential magnetic carriers. J Magn Magn Mater. 2001; 225: 17-20.
83. Mehta RV, Upadhyay RV, Charles SW, Ramchand CN. Direct binding of protein to magnetic particles. Biotechno Techn 1997, 11: 493-496.
84. Koneracka M, Kopcansky P, Timko M, Ramchand CN, Sequeira A, Trevan M. Direct binding procedure of proteins and enzymes to magnetic particles. J Mol Catalysis B Enzymatic 2002; 18: 13-18.
85. Widder KJ, Morris RM, Poore GA, Howard DP, Senyei AE. Selective targeting of magnetic albumin microspheres containing low-dose doxorubicin: Total remission in Yoshida sarcoma-bearing rats. Eur J Cancer Clin Oncol 1983; 19: 135-139.
86. Kubo T, Sugita T, Shimose S, Nitta Y, Ikuta Y, Murakami T. Targeted delivery of anticancer drugs with intravenously administered magnetic liposomes in osteosarcoma-bearing hamsters. Int J Oncol 2000; 17: 309-315.
87. Pulfer SK, Gallo JM. Enhanced brain tumor selectivity of cationic magnetic polysaccharide microspheres. J Drug Target1999; 6: 215-227.
88. Mykhaylyk O, Cherchenko A, Ilkin A, et al. Glial brain tumor targeting of magnetite nanoparticles in rats. J Magn Magn Mater. 2001; 225: (7): 241-247.